Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-26-000045

Chief Financial Officer sold 10,591 shares at $6.82 ($72,227)

From the SEC's structured data for this filing

Trades in this filing

Davis Blaine · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-01-06 Sale : show line 1 in the form −10,591 $6.82 $72,227 121,220 D
Open-market sales · 10,591 sh · avg $6.82 · $72,227
Loading xslF345X05/wk-form4_1767907186.xml…